https://stanfordhealthcare.org/publications/917/917075.html
917075 | Stanford Health Care
Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ study.
stanfordhealthcare